Lessons from that first crowdfunded experiment in 2013
CureFFI.org,
Remember this campaign? With the benefit of nearly a decade of hindsight, we learned a lot from it. Almost a decade ago, you…
Remember this campaign? With the benefit of nearly a decade of hindsight, we learned a lot from it. Almost a decade ago, you…
It’s time to talk again about cell culture systems as tools for prion disease research. I blogged a “brief history” of this…
These are my plain-language notes from a few of the talks at the CJD Foundation’s 2016 family conference held in Washington, D.C.
Or, “Some papers that shape my thinking on prion therapeutics”. Lately I’ve gotten a request from several people, ranging from…
2-aminothiazoles, typified by lead IND24 (above), are a series of antiprion compounds to which the Prusiner lab has devoted…
Motivation As I've discussed on this blog again and again, the most potent small molecules against prion disease in vivo have…
Quinoline derivatives are some of the oldest drugs around. They all stem ultimately from quinine (top left), a natural product…
John Collinge's plenary talk at Prion2015 in Colorado last month got off to a gradual start. He spent the first half hour…
Researchers are ramping up efforts to target tau for Alzheimer’s and other tauopathies.